Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Both) - Abiomed; Boston Scientific Corporation
- Consultant Fee/Honoraria/Speaker's Bureau (Both) - Abbott Vascular; Abiomed; Boston Scientific Corporation; LivaNova; Precardia; Zoll